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Abstract
Background: In vitro cell culture experiments with primary cells have reported that cell proliferation is retarded in the
presence of ambient compared to physiological O2 levels. Cancer is primarily a disease of aberrant cell proliferation,
therefore, studying cancer cells grown under ambient O2 may be undesirable. To understand better the impact of O2 on the
propagation of cancer cells in vitro, we compared the growth potential of a panel of ovarian cancer cell lines under ambient
(21%) or physiological (3%) O2.
Principal Findings: Our observations demonstrate that similar to primary cells, many cancer cells maintain an inherent
sensitivity to O2, but some display insensitivity to changes in O2 concentration. Further analysis revealed an association
between defective G2/M cell cycle transition regulation and O2 insensitivity resultant from overexpression of 14-3-3 s.
Targeting 14-3-3 s overexpression with RNAi restored O2 sensitivity in these cell lines. Additionally, we found that
metastatic ovarian tumors frequently overexpress 14-3-3 s, which in conjunction with phosphorylated RB, results in poor
prognosis.
Conclusions: Cancer cells show differential proliferative sensitivity to changes in O2 concentration. Although a direct link
between O2 insensitivity and metastasis was not determined, this investigation showed that an O2 insensitive phenotype in
cancer cells to correlate with metastatic tumor progression.
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Introduction
Cell lines derived from cancer patients provide an experimen-
tally manipulable model system that facilitates investigations into
cancer biology and its therapy. The unlimited proliferation
potential of cancer cells is a major hallmark of malignancy,
however the use of standard tissue culture protocols often restricts
cell proliferation, as observed with primary cell lines [1,2,3,4].
Although the use of physiological conditions is known to impact in
vitro proliferation of cancer cells [5,6,7] and primary cells are
known to propagate better at physiological O2, the impact of
physiological O2 on in vitro cancer cell proliferation is relatively
unexplored. However, it has been reported that altered concen-
trations of O2 results in clear differences in cell proliferation and
response to drug treatment in the cancer cells [8,9,10].
Oxygen, in addition to nutrients and growth factors, is vital for
proper cell growth and its availability has a direct impact on
cellular metabolism, signaling pathways, proliferation, differenti-
ation and survival [3,11,12,13]. Many in vitro investigations have
demonstrated the advantages of physiological O2 for tissue culture.
For example, the biological behavior of primary cell cultures with
a physiological concentration of O2 (2.7–5.3%) is far superior
compared to the standard practice of growing cells under
atmospheric or ‘‘ambient’’ O2 concentration (21% O2) [4]. In
fact, these two growth conditions are known to result in distinct
metabolic and molecular characteristics [13].
The importance of considering O2 tension in cancer biology is
well established. For example, the fact that many cancers exist in a
‘hypoxic’ state has led to the development of hypoxia-targeted
therapy [14,15]. In general the hypoxic concentration of O2 is
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could vary based on the cell types and the normal perfusion status
[16] and additionally, hypoxia tends to inhibit cell proliferation
[17]. Physiological O2 tension varies from 2.7–5.3% in the
interstitial space [18], where many primary tumors reside, to
14.7% in the arterial circulation and lungs, where migrating and
potentially metastatic cancer cells are often found. Therefore,
cancer studies that are only conducted in ambient (21%) O2 may
miss pertinent biological observations. This may be particularly
important when attempting to study the progression of cancer to
metastatic disease, which is a significant event in cancer etiology
and is associated with poor prognosis [19]. Considering the
differences in O2 tension in different compartments of the body,
an understanding of the effect of O2 concentration on cancer cell
proliferation could provide useful insights into the mechanisms
involved in the pathological progression of cancer.
Cancer cells that have acquired mutations in either oncogenes or
tumor suppressor genes display a characteristic uncontrolled
proliferation phenotype [20]. For example, tumor suppressors such
as p53 or RB act as ‘‘molecular gatekeepers’’ known to affect cell
cycle progression. Mutation of such factors facilitates unlimited
proliferation in cancer cells [20]. Cell cycle progression involves a
sequentialseries of events catalyzed by cyclins and cyclin-dependent
kinases (CDKs) [21], and in normal cells is a tightly regulated
process. The tumor suppressor p53 is a master regulator of G1/S
and G2/M phase transition in the cell cycle [22] and is known to
have an important role in responding to oxygen concentration,
particularly hypoxia (,1% O2) [23] or hyperoxia (95% O2) [24].
Although examining the effect of extreme O2 conditions is both
important andrevealing, it must be notedthat theseprevious studies
did not investigate the response of p53 at physiological (3%) O2 and
ambient (21%) O2. p21 and 14-3-3 s are transcriptional targets of
p53 that are involved in regulating G1/S and G2/M transitions of
thecell cyclebytargeting CDK2 and CDC2 (also knownasCDK1),
respectively [22,25]. The CDKs, in turn, regulate RB protein
function, to mediate cell cycle progression through G1/S and G2/
M [26]. Therefore, disruption of RB function could also impact the
controlof cell cycle progression [26]. Considering that differences in
O2 concentration result in altered cell cycle progression in primary
cells but cancer cells frequently display cell cycle control defects,
there is clearly the potential that these defects may impact how
cancercellsrespond toaltered O2 levelsinamannerthatcouldhave
a profound influence on cancer progression.
Here we examined the biological behavior of ovarian cancer cells
under physiological and ambient O2. Interestingly, some of the
ovarian cancer cell lines had a normal response to O2 concentra-
tion, (i.e. reduced cell proliferation with increased O2 concentration)
while the proliferation of other ovarian cancer cell lines was
unaffected by this O2 increase. Further, our investigations revealed
that 14-3-3 s and its role in the cell cycle influence the proliferative
response to altered O2 levels. Considering the variation in partial
pressure of oxygen throughout the body and the potential
importance that this context may have on cancer progression, it is
crucial to understand the affect of O2 concentration on cancer cell
proliferation and cancer progression. We provide evidence that
acquisition of O2 insensitivity may be a component in cancer
progression and a hallmark of successful metastatic disease.
Results
Physiological oxygen results in increased cell
proliferation in ovarian cancer cells
In our initial studies we compared the effect of physiological (3%
O2) and ambient (21% O2) oxygen concentration using A2780
ovarian cancer cells and observed that 12 days of cell culture under
these conditions resulted in a 2.6 fold growth suppression under
21% O2 (Figure 1). Therefore, we examined the affect of O2
concentration onthegrowth potentialof six ovariancancercell lines
using physiological (3% O2) and ambient (21% O2) oxygen
concentrations. Since the serum present in cell culture medium
can also have a dominant influence on growth, we also tested the
affect of various concentrations of serum. Regardless of the amount
of serum present in the growth medium, culturing in 21% O2
generally resulted in a significant decrease in cell proliferation for
four of the ovarian cancer cell lines (A2780, OVCAR5, OVCAR8
and HOC8) compared to 3% O2 (Figure 2). The only exception
observed was with HOC8 cells in the presence of the highest
concentration of serum (10% v/v), where an insignificant O2-
dependent growth effect was observed (Figure 2). Presumably the
lack of response in Hoc8 results from a dominant influence of
serum, which was not observed with A2780, OVCAR5 and
OVCAR8. In contrast, there was no significant effect on the growth
of SKOV3 and HeyA8 cell lines by increasing the O2 concentration
to 21%, irrespective of serum concentrations (Figure 2). The
observed exception was HeyA8 cultured under 2% serum, which
showed decreased cell proliferation at 21% O2 compared to 3% O2
(p,0.001). In contrast to the effect of O2 levels, increasing the
concentration ofserumresulted ina proportionalgrowth increasein
the ovarian cancer cell lines A2780, OVCAR5 and OVCAR8
(p,10
25, Figure 2). The concentration of serum had a moderate
influence on growth in SKOV3 and HeyA8 (Figure 2); a serum
concentration between 2 and 6% had a significant effect (p,10
25)
in SKOV3, while HeyA8 serum concentration between 2 and 10%
serum had the greatest effect at 3% O2 (p,10
25) (Figure 2).
Increasing serum concentration from 6% to 10% had little effect on
growth of HeyA8, SKOV3 and HOC8 (Figure 2). Together, it
appears that both oxygen levels and serum concentration affect the
growth of these ovarian cancer cell lines, but in an independent
fashion. As expected from work by others with primary cells [4], we
observed that the majority of the ovarian cancer cells displayed
decreased cell proliferation at ambient O2 concentration compared
to physiological O2 concentration. However, two cell lines did not
appear to have inhibited cell proliferation at the higher (ambient)
O2 levels. We therefore categorized the ovarian cancer cell lines
based on these differences, being either O2 sensitive (A2780,
OVCAR5, OVCAR8 and HOC8) or insensitive (SKOV3 and
HeyA8) (Figure 2). Overall, these differences suggest heterogeneity
in growth regulation responses to physiological cues of O2 levels in
these cultured cell lines.
It is possible that the apparent O2 insensitivity and differences in
proliferation resulted from differences in the doubling time of each
cell line. For example, if SKOV3 and HeyA8 (the O2 insensitive cell
lines) proliferate more slowly, O2 dependent proliferation changes
may be too trivial to measure. Therefore, we measured the cell
doubling time for all ovarian cancer cell lines. Our results showed
that under standard tissue culture conditions (10% serum and 21%
O2) the doubling time for all ovarian cancer cell lines were
somewhat similar (,24 hours) except for HOC8, which had an
extendeddoubling time ofabout 45.564.9 hours(TableS1,and see
Methods S1). Therefore, most of the ovarian cancer cell lines were
dividing at an approximately equal rate, and gross difference in
doubling time is unlikely to be a factor in the observed proliferation
differences between cell lines under different conditions.
Oxygen sensitivity correlates with dynamic changes in
the S and G2 phases of the cell cycle
Considering the differences in proliferation observed for ovarian
cancer cell lines grown under either 3% or 21% O2, we examined
Oxygen and Cancer Cell Cycle
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line. Irrespective of serum concentration, comparing 3% O2 to
21% O2 resulted in a significant decrease in the percentage of cells
that were in the G1 phase of the cell cycle and a significant
increase in the percentage of cells in S phase (Table 1), which was
expected based on previous observations made with primary cells
[27]. Furthermore, in three of the O2 sensitive cell lines (A2780,
OVCAR5 and OVCAR8) the percentage of the cell population in
the G2 phase was increased significantly in 21% O2. However a
significant increase in G2 was not observed in the fourth O2
Figure 1. Cancer cell proliferation is markedly suppressed by the standard cell culture conditions used for in vitro experiments.
Equal numbers of A2780 ovarian cancer cells were seeded in a 10 cm petri dish and were routinely maintained under 3% O2 (physiological) or 21% O2
(ambient). The increase in cell numbers was determined by counting manually once in three days, and the total cell numbers were estimated and
plotted using linear scale (in Graph A) and log scale (in Graph B).
doi:10.1371/journal.pone.0015864.g001
Figure 2. Ovarian cancer cells grown under physiological and ambient O2 show differential proliferation response. Ovarian cancer cell
lines were cultured under 3% or 21% O2 and the extent of proliferation was determined following 3 days of growth (see Materials and Methods
section). For each cell line, the percent of cell proliferation at 3% O2 (light shaded bars) and at different concentrations of serum was compared with
proliferation under standard tissue culture conditions consisting of 21% (ambient) O2 (dark shaded bars) and 10% FBS. The error bars represent the
standard deviations of mean and statistical significant (by student T Test) differences in proliferation between 3% and 21% O2 for each concentration
of serum is indicated by an asterisk [(*) p,0.05, (**) p,0.001 and (***) p,0.0001].
doi:10.1371/journal.pone.0015864.g002
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insensitive cell lines, SKOV3 and HeyA8, did not display a
significant alteration in the proportion of cells in the G2 phase of
the cell cycle when grown under 3% O2 or 21% O2 (Table 1).
Considering that the O2 sensitive cell lines proliferated more
slowly at 21% O2 compared to 3% O2 despite having smaller
proportions of their cell population in G1 and a increased
proportions in S and G2, we conclude that these cells must be
progressing more slowly through the cell cycle. However, for the
O2 insensitive cell lines and HOC8 (with the significantly extended
doubling time), we did not observe a significant increase in the
percentage of cells in G2 when the O2 levels were increased. These
results suggest that although the G1 and S phases of the cell cycle
are responding similarly to changes in O2 concentration in both
O2 sensitive and insensitive cell lines, it is the G2 phase of the cell
cycle that is not responsive to O2 concentration in the O2
insensitive cell lines. Therefore, the difference in cell cycle response
observed with these ovarian cancer cell lines might be at the level
of regulation during the cell cycle progression from G2 to M
phase. It is also possible that the changes observed with G2 and O2
sensitivity in these cancer cell lines is reflected in the mitotic
component of the cell cycle. Our observation of the mitotic cells
present in the O2 sensitive and insensitive cell lines grown under
3% and 21% O2 supports this conclusion; the O2 sensitive cell
lines show a proportionate decrease in the mitotic cell population
observed at 21% O2 compared to 3% O2, (Figure 3), correspond-
ing to an accumulation of cells at G2 at 21% O2 (Table 1).
Similarly, in the O2 insensitive cell lines (HeyA8 and SKOV3) the
proportion of mitotic cells remained unaltered regardless of O2
concentrations (Figure 3). This is expected because, as noted
previously (Table 1), the proportion of cells at G2 in the O2
insensitive cell lines were also unaffected by O2 concentration. We
conclude that most cancer cells retain an ability to regulate cell
cycle in response to changes in O2 concentration comparable to
wild type cells [27]. However, some cancer cells may lose O2
concentration dependent control of cell cycle (as in the O2
insensitive cancer cell lines), resulting in a distinct phenotype.
Oxygen insensitivity correlates with altered G2/M
components
Thus far we have demonstrated that O2 sensitive cell cycle
response at the G2/M transition is lacking in the O2 insensitive cell
lines. We therefore went on to characterize this observation further
by determining what component of G2/M regulation is deficient in
the O2-insensitive cancer cells. The major effector of G2/M
transition is CDC2 [22,28]. CDC2 forms a complex with cyclin B
[29,30], which phosphorylates various structural proteins resulting
in the collapse of the nuclear envelope, condensation and
segregation of chromosomes [30,31] and inactivation of other cell
cycle regulatory proteins such as WEE1, RB and CDC25C [30,32].
In normal cells, the overall levels of CDC2 protein are kept constant
throughout the cell cycle [33] and are regulated by post-
translational modification [33] and cellular localization [30,31].
Once the Tyr15 residue on CDC2 is dephosphorylated by
CDC25C, activated CDC2 forms a complex with cyclin B,
accumulates in the nucleus, and promotes the G2/M transi-
tion[30,33,34]. This occurs in a stepwise fashion through increasing
amounts of nuclear CDC2 protein [30]. Our examination of total
CDC2 protein and phosphorylated CDC2 protein revealed that
both are considerably lower in the O2-insensitive cell lines (HeyA8
and SKOV3) compared to the O2-sensitive cell lines (Figure 4A).
Although the levelsofCDC2wererelatively high intheO2-sensitive
cell lines (A2780, OVCAR5 and OVCAR8) (Figure 2), we observed
a decrease in Tyr15 phosphorylation status regardless of O2
concentration for A2780, OVCAR5 and OVCAR8 with increasing
serum levels (Figure 4A). This correlates with the observation that
increasing serum concentration causes increased cellular prolifera-
tionand results in a concomitant reduction in the proportion of cells
inG2/M(comparewithTable1).However,noovert O2-dependent
alteration in either total or phosphorylated cyclin B or CDC25C
was observed in the O2 sensitive cell lines (A2780, OVCAR5,
OVCAR8 and HOC8) compared to O2 insensitive cell lines
(HeyA8 and SKOV3) (Figure 4A). Therefore, it appears that the
observed decrease in the cell population in G2 in 21% O2 might not
be dependent on phosphorylation-mediated inactivation of CDC2.
It should be noted that these experiments were performed in
asynchronously growing cells, and therefore it is possible that
transient differences in CDC2 status were missed. Interestingly, the
levels of CDC2, Cyclin B and CDC25c (the negative regulator of
CDC2) were considerably lower in O2 insensitive cell lines (HeyA8
and SKOV3) compared to O2 sensitive cell lines (A2780,
OVCAR5, OVCAR8 and HOC8) (Figure 4A). These observations
suggest an inherent deficiency in the core components involved in
the G2/M progression in the O2 insensitive cell lines.
p53, p21 and 14-3-3 s are factors which have the ability
negatively to influence CDC2 activity and G2/M transition [22].
Current understanding is that p53 and p21 influence cell cycle in
hypoxic and hyperoxic conditions [23,24,35,36]. Considering the
reduced levels of CDC2 and the apparently defective G2/M
checkpoint in the O2 insensitive cell lines (HeyA8 and SKOV3), we
explored the possibility that impairment was due to a defect in any
of these molecular regulators. Western blot analysis found p53 and
p21 to be overexpressed in one O2-insensitive cell line (HeyA8).
However, both were absent in the other O2-insensitive cell line
(SKOV3), and the expression pattern for these proteins remained
unaltered regardless of changes in O2 or serum concentration
(Figure S1), suggesting that neither p53 nor p21 is relevant to
CDC2’s function in O2 sensitivity. Interestingly, we observed a
considerable elevation in the expression of 14-3-3 s (Figure 4A) in
the O2 insensitive cell lines (HeyA8 and SKOV3) compared to the
O2-sensitive cell lines. Although, the level of 14-3-3 s expression
was considerably lower in all O2-sensitive cell lines compared to
HeyA8andSKOV3,wedidobserveanincreaseintheexpressionof
14-3-3 s at 21% O2 with A2780 (Figure 4A). Although
Figure 3. Mitotic index in the ovarian cancer cell lines grown
under 3% or 21% O2. Mitotic index in the ovarian cancer cell lines
that were cultured under 3% or 21% O2 for 3 days were determined by
counting nuclei with condensed chromosomes, among the minimum of
1000 cells present in each experiment. Statistical significance was
determined by ANOVA and the significant difference in the mitotic
index between 3% and 21% O2 is denoted by an asterisk [(*) p,0.05,
(***) p,0.0001].
doi:10.1371/journal.pone.0015864.g003
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activity, we concluded that high levels of 14-3-3 s combined with
reduced levels of CDC2 in a proliferating cancer cell may indicate a
lack of control of G2/M progression in response to O2 levels.
To clarify the consequence of the low levels of CDC2 protein
observed in the O2-insensitive cell lines, we determined the
functional activity of the remaining CDC2 by examining the
phosphorylation of two of its substrates, RB and WEE1.
Phosphorylation of RB at the Ser 807 residue is mediated by
CDC2 [32], and we observed this phosphorylation regardless of
CDC2 levels or O2 levels with 10% serum for all cell lines except
HOC8 (Figure 4B), indicating unimpaired CDC2 activity in these
cell lines. A reduction in phosphorylated RB correlated with
reduction of serum concentration (Figure 4B) and correlated with
increased accumulation of total RB in the O2-sensitive cell lines
(A2780, OVCAR5 and OVCAR8), but not in HOC8 (Figure 4B).
Total RB was barely detectable in the O2-insensitive cell lines
(HeyA8andSKOV3)(Figure4B),withtheexceptionof2%serumat
3% O2 condition in the HeyA8 cell line. Interestingly, a comparison
between the RB expression pattern (Figure 4B) and cell proliferation
(Figure 2) revealed that HOC8, HeyA8 and SKOV3 cells grow
betterincellculture medium with a low concentration ofserum (2%)
compared to A2780, OVCAR5 and OVCAR8. It therefore appears
thatthetotalRBproteinlevelresponseremainsintactinO2-sensitive
cell lines and that this response is probably more relevant to serum
concentrations than O2 levels. The other target for CDC2-mediated
inactivation by phosphorylation is WEE1, which can also recipro-
cally inhibit CDC2 function by phosphorylation [37]. We observed
increased phosphorylation of WEE1 in the O2 sensitive cell lines
(A2780, OVCAR5 and OVCAR8), barely detectable levels in
HOC8,(Figure 4B)anda completeabsence inthe O2-insensitivecell
lines (HeyA8 and SKOV3, Figure 4B). This pattern was largely
recapitulated for total WEE1 protein levels (Figure 4B). Therefore,
the absence of phospho-WEE1 in the O2-insensitive cell lines does
not indicate an absence of CDC2 activity, but rather an absence of
the WEE1 substrate. From these results we concluded that despite
the reduced amounts ofCDC2 inthe O2-insensitivecelllines,CDC2
is functionally active and uninhibited by the increased levels of 14-3-
3 s. It should be noted that RB and CDC2 act upon each other to
regulate each others function [38], and phosphorylation status of RB
[26] or CDC2 [39] could influence E2F mediated expression of
cyclins that are essential for cell cycle progression. Therefore,
considering this complex relationship between RB and CDC2, the
phosphorylation pattern of RB is insufficient to predict G2/M
progression.
In summary, the O2-sensitive cell lines (A2780, OVCAR5 and
HOC8) showed increased expression of CDC2 and cyclin B
combined with low level of 14-3-3 s expression. This suggests that
the cell cycle components required for a dynamic proliferative
response to differences in the O2 concentration is present in these
cell lines. However in the O2-insensitive cell lines that express high
levels of 14-3-3 s and low levels of CDC2 and CDC25C such a
dynamic cell cycle response to changes in O2 concentration could
be impaired. We therefore pursued the possibility that this inverse
correlation between 14-3-3 s and CDC2 might be important for
the O2-sensitive regulation of G2/M transition.
14-3-3 s and mitotic progression in oxygen sensitivity
Our previous observations suggest an association between
elevated level of 14-3-3 s and O2-insensitivity that needs to be
confirmed. Therefore, we wanted to confirm that 14-3-3 s does
indeed affect O2-dependent proliferation. For this part of the study,
we restricted our analysis to two cell lines with wild type p53: the
O2-sensitive A2780 [40], and O2-insensitive HeyA8 cell lines [41].
Table 1. FACS profile for cell cycle analysis with ovarian cancer cells that were grown under cell culture conditions consisting of
increasing serum and O2 concentration.
Cells Serum G1 S G2
3% O2 21% O2 p-value 3% O2 21% O2 p-value 3% O2 21% O2 p-value
2% 66.860.9 62.560.2 0.0011 25.661 27.560.1 0.02800 7.660.4 9.9660.1 0.0007
A2780 6% 76.962.1 64.360.7 0.0006 17.560.9 2960.1 ,0.0001 5.661.4 6.760.6 **NS**
10% 84.163.2 69.561.4 0.0028 14.361.9 26.561.3 0.0080 1.561.3 460.7 0.0411
2% 66.460.7 60.260.4 0.0001 25.860.2 29.360.6 0.0006 7.760.5 10.460.3 0.0017
OVCAR5 6% 7961.5 70.260.5 0.0014 17.461.5 25.160.9 0.0015 3.460.4 4.760.6 **NS**
10% 90.661.2 8461.6 0.0077 8.261.4 14.661.5 0.0052 1.160.1 1.262.1 **NS**
2% 74.7610.7 6961 **NS** 15.562.5 23.760.6 0.0052 13.762.3 660 0.0043
OVCAR8 6% 66615 9 61 0.0010 25.761.5 3060 0.0079 7609 . 7 60.6 0.0013
10% 6964.6 61.761.5 0.0582 24.361.5 30.761.2 0.0045 5.363.8 6.360.6 **NS**
2% 69.361.5 58.762.1 0.0020 25613 4 61 0.0003 4.361.5 5.761.5 **NS**
HeyA8 6% 62.760.6 53.761.5 0.0006 30.361.2 37.362.5 0.0118 5.360.6 863.5 **NS**
10% 61.761.2 50.362.3 0.0016 30.761.2 37.361.2 0.0021 6.762.3 1161.6 **NS**
2% 8061.7 72.361.5 0.0045 1560 18.761.5 0.0141 561.7 861 **NS**
HOC8 6% 80.361.2 72.761.2 0.0012 15.361.5 22.761.5 0.0041 3.361.5 3.761.5 **NS**
10% 78.762.5 73.360.6 0.0232 16.360.6 23.760.6 ,0.0001 4.362.5 361 **NS**
2% 7462 62.161.7 0.0014 13.563.5 27.761.2 0.0026 1262 10.362.5 **NS**
SKOV3 6% 76.761.5 65.363.2 0.0052 1461 25.761.5 0.0003 9.361.5 962 **NS**
10% 80.361.2 6861.7 0.0005 12.761.5 2661 0.0002 7616 . 3 60.6 **NS**
**NS** ‘‘Not Significant’’
doi:10.1371/journal.pone.0015864.t001
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expression levels of 14-3-3 s and CDC2 (Figure 4A). However,
since the functional responses of these proteins are dependent on
their cellular localization, we used immunofluorescence to deter-
mine their cellular location under 3% O2 and 21% O2. In the O2-
sensitive A2780 cell line, the localization of 14-3-3 s was restricted
to the cytoplasm under 3% O2 (Figure 5A), but was found in both
the nucleus and cytoplasm at 21% O2 (Figure 5A). CDC2 was
distributed throughout the cell and its localization wasunaffectedby
O2 concentration. It therefore appears that nuclear exclusion of 14-
3-3 s correlates with a decreased fraction of cells in the G2/M
phase and an uninhibited cell cycle progression when A2780 is
grown at 3% O2, as noted before (Table 1). In contrast, the O2-
insensitive HeyA8 cell line showed high levels of 14-3-3 s and low
levels of CDC2 (Figure 4A), with a considerable amount of 14-3-3s
in the cytoplasm (Figure 5A). Further, 14-3-3 s remained excluded
from the nucleus even at 21% O2 in the HeyA8 cells (Figure 5A).
These observations were further verified by Western blot analysis of
nuclear and cytosolic cell fractions obtained from these cells
(Figure 5B). Finally, to confirm the effect on G2/M transition, we
determined the proportion of those cells in M phase for different O2
concentrations using the mitosis specific marker phospho-histone
H3. In the O2-sensitive A2780 cells, under 21% O2, we observed a
decrease in the mitotic index (P,0.001), compared to 3% O2
(Figure 5C). No such O2-dependent change in mitotic index was
observed for the O2-insensitive HeyA8 cells (Figure 5C). These
results support our initial conclusion, that the O2-insensitive cells
lines have a deficiency in regulating cell cycle progression at G2/M
in response to increased O2 levels (Figure 2).
The levels and cellular localization of 14-3-3 s correlate with O2-
sensitive proliferation. To demonstrate a direct relationship, we
examined whether over-expression of 14-3-3 s could render O2-
sensitive A2780 cells insensitive to O2 and conversely whether
reducing the levels of 14-3-3 s in O2-insensitive HeyA8 cells could
restore O2-sensitivity. Transient over-expression of 14-3-3 s in
A2780 cellsreduced cellproliferation(Figure5D)andresultedinloss
of O2-sensitivity. Therefore, merely increasing 14-3-3 s expression
results in its inability to regulate G2/M in the absence of any further
genetic alterations. Conversely, RNAi-mediated silencing of 14-3-3
s expression in HeyA8 cells (Figure 5E - Western blot) resulted in a
substantial increase in proliferation under 3% O2 (Figure 5E - Bar
graph). Interestingly, when the cells from the same siRNA
transfection were placed at 21% oxygen, 14-3-3 s protein
expression was induced, reducing the knockdown effect of the
siRNA. This observation also suggests an O2-dependent transcrip-
tional response by 14-3-3 s. Despite this transcriptional response,
we still observed a muted growth phenotype at 21% O2 under these
conditions. Togetherthese experimentsdemonstrate that 14-3-3s is
a critical factor for controlling ovarian cancer cell proliferation in
response to O2 concentration.
14-3-3 s is frequently highly expressed in ovarian cancer
and its ineffectiveness in controlling CDC2 is relevant to
ovarian tumor pathology
Considering that increased expression of 14-3-3 s provides
some indication of impaired G2/M control, it is possible that
cancer cell lines that express high levels of 14-3-3 s are O2-
insensitive. The O2-insensitive ovarian cancer cell lines we have
Figure 4. Western blot analysis of G2 cell cycle regulatory proteins and the relevance to O2 sensitivity in the ovarian cancer cell
lines. Protein lysates prepared from the ovarian cancer cell lines maintained in growth medium consisting of increasing concentrations of serum and
21% or 3% O2 were analyzed by Western blot. (A) Compared to O2 sensitive cell lines, decreased expression of the core components involved in G2/M
cell cycle progression CDC2/cyclin B1 complex and its activator CDC25c is observed in the O2 insensitive cell lines (indicated by asterisk and italics),
while the expression of 14-3-3 s, a protein that inhibits CDC2 is elevated in the O2 insensitive cell lines. (B) Phosphorylation of RB and Wee1 were
monitored as an indicator for CDC2 function because both RB and Wee1 are known targets for phosphorylation by CDC2. Equal loading of protein
extracts were monitored by probing the stripped Western blots with the primary antibody for b-actin.
doi:10.1371/journal.pone.0015864.g004
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CDC2 protein levels. It is conceivable that the same phenotypic
defect might result from cells with unchecked CDC2 activity,
irrespective of 14-3-3 s levels. To determine the frequency of
commonly available cancer cell lines that have the hallmarks of
O2-insensitivity, we used a reverse phase protein array (RPPA) and
screened 57 different ovarian cancer cell lines for the levels of
14-3-3 s and CDC2, as well as phospho-RB as an indicator of
CDC2 activity. Cell lines with the same name but from different
labs or different passages were considered to be different. We
therefore set the analysis criteria on the RPPA array to detect high
phospho-RB (P-RB) and either high 14-3-3 s or high CDC2. In
the context of high levels of P-RB, this criteria should indicate that
either 14-3-3 sis dysfunctional or that active CDC2 is uninhibited,
Figure 5. 14-3-3 sand O2 sensitivity. (A) Cellular localization by immunofluoresence shows that 14-3-3 s (Green) is located in the cytoplasm and
CDC2 (Red) is present in the nucleus (Blue). Compared to O2 sensitive A2780 cells, the level of 14-3-3 s is higher and CDC2 is low in the O2 insensitive
HeyA8 cells. In the O2 sensitive A2780, 14-3-3 s is localized both in the nucleus and cytoplasm at 21% O2. (A dotted yellow line, outlines a
representative nuclei to indicate relative localization of 14-3-3 s and CDC2 in these cells). (B) Western blot analysis of nuclear and cytoplasmic
fractions show low levels of 14-3-3 s in the nucleus compared to cytoplasm, with increased amounts of 14-3-3 s being present in the cytoplasm of
the O2 insensitive HeyA8 cells. The level of CDC2 is higher both in the nucleus and cytoplasm of the O2 sensitive A2780, but present in lower amount
only in the nucleus of O2 insensitive HeyA8 cells. Histone H1 and b2actin were used as loading controls for nuclear and cytoplasmic fractions,
respectively. (C) Mitotic cells were determined by counting the cells that stained positively for a mitosis specific marker, Phospho-Histone H3 from the
total cell population. Mitotic fractions present at 3% or 21% O2 were counted in both A2780 and HeyA8 and represented as bar graph. A significant
increase in mitotic index (p.0.001, indicated by asterisk) was observed in the O2 sensitive A2780 at 3% O2, but not in the O2 insensitive HeyA8 cells.
(D) Over-expression of 14-3-3 s in the O2 sensitive A2780 (Western Blot) results in loss of O2 sensitivity (Bar graph). For the cells transfected with
empty vector (mock transfection) or 14-3-3 s over-expression construct, the percent of cell proliferation was compared with proliferation of mock
transfected cells grown under standard tissue culture conditions consisting of 21% O2 (ambient), and (E) in the converse experiment performed with
O2 insensitive HeyA8, reducing the levels of 14-3-3 s by siRNA (Western blot) results in restoration of O2 sensitivity (Bar graph). For the cells
transfected with scrambled siRNA (mock transfection) or siRNA against 14-3-3 s, the percent of cell proliferation was compared with proliferation of
mock transfected cells grown under standard tissue culture conditions consisting of 21% O2.
doi:10.1371/journal.pone.0015864.g005
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degradation [42] We observed that of the 57 ovarian cancer cell
lines represented in the RPPA, 28 cell lines (49%) showed high
levels of 14-3-3 s (Figure 6A) of which 16 cell lines (28%) also had
increased P-RB, corresponding to the O2 insensitivity pattern we
have described. Amongst these 16 cell lines, 6 also have increased
levels of CDC2 while the remainder had decreased levels of
CDC2. This suggests that this protein profile is not exclusive to the
cell lines we originally identified and might be representative of a
relatively common phenomenon. We therefore determined
whether this O2-insensitive associated 14-3-3 s/CDC2/P-RB
protein profile is also observed in ovarian tumor samples. Using
the same criteria as with the cell line RPPA, we examined 205
ovarian tumor specimens using RPPA. This analysis revealed that
27% of ovarian tumors (56) had elevated levels of both 14-3-3 s
and P-RB, and amongst these, 34 also had elevated levels of
CDC2 expression (Figure 6B). These results are very comparable
with the RPPA analysis of the ovarian cancer cell lines (Figure 6A).
Ovarian cancer has a poor survival rate and this is often
associated with metastatic progression [43]. The O2-insensitive
associated 14-3-3 s/CDC2/P-RB protein profile suggests an
unrestricted G2/M control in response to changes in O2 levels,
such as a migrating or metastatic cancer would encounter.
Therefore, it is possible that this protein profile is associated with
poor prognosis. Using the O2-insensitive associated protein profile
(high P-RB with either high 14-3-3 s or high CDC2) we identified
47 of 158 tumors with associated clinical data. A Kaplan-Meier
survival estimate shows that patients with the O2-insensitive
associated protein profile have a poor survival outcome (less than
90 months compared to 200 months observed otherwise,
p=0.016, Figure 6C). Altogether it appears that the O2-insensitive
associated protein profile suggests that unrestricted G2/M
accompanies a substantial proportion of ovarian cancer cells and
primary tumor samples. Further, this O2-insensitive profile is
associated with poor prognosis for this disease.
Elevated 14-3-3 s expression in metastatic ovarian
tumors
Having observed that the O2-insensitive associated protein
profile (high P-RB with either high 14-3-3 s or high CDC2) is
both relatively common in ovarian cancer and associated with
poor prognosis, we went on to determine directly whether
metastatic ovarian tumors exhibit an overt 14-3-3 s signature.
Of note, the ovarian tumors represented in the ovarian tumor
RPPA are from primary sites and thus do not necessarily provide
an accurate representation of the protein profile in the metastatic
cancer. We therefore expect that metastatic tumors or primary
tumors that give rise to metastatic tumors will exhibit a more overt
14-3-3 s signature than primary tumors. In fact, an increased
expression of 14-3-3 s has been previously reported with other
tumors [44] and a functional involvement for 14-3-3 s in
metastatic disease is known [45,46]. We analyzed 14-3-3 s
expression using immunohistochemistry on paraffin embedded
tissues obtained from 10 different metastatic ovarian tumors and
their corresponding primary site tumors. We consistently observed
intense immunostaining of 14-3-3 s in 8/10 metastatic tumors
and the corresponding primary tumors (Figure 7j–l). In contrast,
the primary tumors without metastasis at diagnosis showed
moderate immunostaining for 14-3-3 s, and occasionally intense
staining was also noted (Figure 7i). Borderline tumors showed a
mild to moderate staining pattern for 14-3-3 s, while in normal
tissues, protein levels were absent or diffusely present (Figure 7 a–
c). Increased expression of 14-3-3 s in the metastatic primary
tumors compared to normal tissue or malignant tumors without
metastasis were observed to be statistically significant by the
Fisher’s exact test (Figure 7, Bar Graph). The high level of 14-3-3
s expression offers the first indication of the manner in which
regulation of G2/M may be dysfunctional in these tumors.
Over-expression of 14-3-3 s in metastatic disease is not
unexpected and has been previously noted [45,46,47]. However,
we speculate the reason for this association is due to a loss of O2-
sensitivity and that this provides a selective advantage for
metastatic progression. Our conclusion is that O2-sensitive and
insensitive patterns of 14-3-3 s and CDC2 expression are readily
detectable and common to cancer cells, regardless of whether they
are grown in vivo or in vitro. Further, these expression patterns may
have prognostic implications, but additional experiments will be
required to confirm the mechanistic relevance of O2-sensitivity in
the clinical progression of cancer.
Discussion
There is an increasing interest to study cell biology under the
context of physiological O2 levels. Investigations with primary
mouse embryonic fibroblasts comparing the effects of physiological
(3%) and ambient (21%) oxygen, show that 21% O2 causes
increased oxidative stress and induces senescence [4]. Several
studies conducted with embryonic stem (ES) cells reported that
characteristic stem cell properties are preserved only when ES cells
are maintained under physiological O2- ES cells otherwise
differentiate under ambient O2 as reviewed in [2]. This prompted
us to investigate the effects of physiological (3%) and ambient
(21%) oxygen in the context of cancer. With A2780 ovarian cancer
cells grown under 21% or 3% O2, a 20% growth suppression was
observed with 21% O2 by three days (Figure 2) and although the
proportional changes to cell cycle profile appear small, they were
significant (Table 1). The accumulated effect of these differences in
proliferation and cell cycle resulted in a 2.6 fold difference to the
growth of the cancer cells by 12 days in the presence of different
O2 concentrations (Figure 1). This observation demonstrates that
standard tissue culture conditions may adversely impact the in vitro
proliferation of cancer, which is primarily a disease of prolifera-
tion. Previous studies compared the growth of primary mouse
embryonic fibroblast cells [4], adult human fibroblasts [48] and
human cancer cells [8] grown under physiological (3–5%) or
ambient (21%) O2 and observed increased cell proliferation under
physiological O2. In this study, we observed similar effects with
ovarian cancer cells (A2780, OVCAR5, OVCAR8 and HOC8 -
Figure 2), however other cells lines failed to respond to O2
concentration (HeyA8 and SKOV3) (Figure 2). These proliferative
responses to O2 seem to affect all phases of the cell cycle,
particularly the G1 and S phases of cell cycle, in all cell lines.
However, only the G2 phase was affected in cell lines which
displayed proliferative response to 3% O2 (Table 1), suggesting the
possibility that the G2 phase transition of the cell cycle is crucial
for regulating proliferation in response to differences in 3% O2
levels. A change in the G2 phase in response to O2 levels was
reported in only one other study performed with Fanconi anemia
(FA) cell lines [49]. Analogous to our study, the experiments with
FA cells demonstrated a characteristic G2 delay with standard
tissue culture conditions (20% O2), but a reduced proportion of
cells in G2 and increased proliferation when cultured at 5% O2
[49]. Furthermore, growth of different human fibroblast cells
under physiological O2 has also been observed to be accompanied
by a reduction in the G2 cell population [27,48]. Overall, it
appears that the G2 phase is the most O2-sensitive phase of the cell
cycle. Exploring the possible molecular mechanisms that render
ovarian cancer cells either sensitive or insensitive to oxygen has
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CDC2 dependent G2/M transition in response to O2 levels that
results in oxygen-insensitive cell lines. Although expression of 14-
3-3 s is regulated by p53 [25], we observed no difference in the
levels of p53 expression under different oxygen concentrations
(Figure S1), suggesting that the involvement of 14-3-3 s in O2-
sensitivity is independent of p53. If the decrease in 14-3-3 s is
associated with oxygen-sensitive increase in proliferation, then
silencing the expression of 14-3-3 s in oxygen-insensitive cell lines
should restore proliferative sensitivity to oxygen. In fact, our
experiments show that RNAi mediated silencing of 14-3-3 s in
HeyA8 cells restored oxygen sensitivity (Figure 5E) and in a
converse experiment, over-expression of 14-3-3 s abolished
oxygen sensitivity in the A2780 cell line (Figure 5D). This suggests
that high levels of 14-3-3 s protein is sufficient to restrict the
regulation of CDC2 mediated G2/M progression. The cytoplas-
mic restriction of overexpressed 14-3-3 s in the O2-insenstive
HeyA8 cells provides the first indication for the possible
mechanistic basis of this dysregulation (Figure 5A). Other reports
also show preferential changes to cellular localization of 14-3-3 s
during different phases of the cell cycle [50], suggesting that cell
cycle changes observed with oxygen could be relevant to the 14-3-
3 s localization and pattern in our experiments. Furthermore, 14-
3-3 s is actively exported out of nucleus by CRM1, [51], a nuclear
Figure 6. Reverse phase protein array data analysis. (A) Hierarchical clustering of normalized RPPA data over Phospho-RB (Ser 807/811), 14-3-3
s, CDC2 and p53 across 57 ovarian cancer cell lines. (B) Hierarchical clustering of normalized RPPA data over Phospho-RB (Ser 807/811), 14-3-3 s,
CDC2 and p53 across 205 ovarian tumors. The color codes for overall survival represents overall survival .24 months (blue) and overall survival ,24
months (pink). The color codes for tumor stage represent stage I (red), stage II (green), stage III (light-blue) and stage IV (dark-blue). (C). Kaplan-Meier
survival curve for the RPPA results comparing the group of ovarian tumors with high Phospho-RB and high 14-3-3 s or CDC2 (blue line) with other
expression profiles (red line).
doi:10.1371/journal.pone.0015864.g006
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host of other factors such as, BRCA1, p63 and estrogen induced
zinc finger protein (EFP) are also known to regulate the levels of
14-3-3 s [53]. Therefore, it is possible that 14-3-3 s expression
and its cellular distribution could be influenced by several factors,
independent of p53 (as must be the situation in the O2 insensitive
p53 null cell line SKOV3).
The differences in O2-sensitivity and, consequently, cell
proliferation is most important when trying to recapitulate in vivo
responses where physiological O2 tensions vary from 2.7–5% in
the interstitial space (where many cancer cells reside) to 14.7% in
the arterial circulation and lung [18]. Thus, it is reasonable to
predict that if O2-sensitive cancer cells were to dislodge from a
primary interstitial space and migrate to the lungs via blood
circulation, the increased O2 concentration would restrict
proliferation. In contrast, we speculate that oxygen insensitive
cancer cells would have a selective advantage compared to
sensitive ones, being better able to thrive in the conditions of
increased oxygen concentration. In fact, 14-3-3 s is frequently
over-expressed in many thyroid [54], colorectal [55] and prostate
[56] tumors, and is also a potential target for therapeutic
modulation [55,56]. Our results provide one rationale for selecting
the cancers best suited for 14-3-3 s targeted therapy. Oxygen
insensitivity observed in HeyA8 or SKOV3 is less likely an
adaptation to in vitro growth conditions because transient over-
expression of 14-3-3 s renders O2-sensitive A2780 cell line
insensitive to increased levels of O2 (Figure 5D), and over-
expression of 14-3-3 s is observable in primary tumors with
metastatic potential (Figure 7). Oxygen sensitivity could therefore
be an important factor in the context of metastatic spread of
cancer because over-expression of 14-3-3 s is frequently observed
in metastatic cancers, including this study (Figure 7) and others
(gastric [57], endometrial [58] and pancreatic [59]). However,
epigenetic inactivation of 14-3-3 s by gene methylation has also
been reported to correlate with decreased expression of 14-3-3 s
in cancer progression [60] and metastasis of certain types of
tumors [61]. Further, a correlation with a functional role for 14-3-
3 s in promoting tumor invasion and metastasis has also been
demonstrated [45,47,62]. Taken together, there is ample evidence
to support that over-expression of 14-3-3 s is relevant to tumor
metastasis and therefore, it is likely that O2 insensitivity associated
with over-expression of 14-3-3 s may have a pivotal role in
metastatic dissemination of tumors. Further support to demon-
strate the explicit role of 14-3-3 s in in vivo O2 sensitivity and its
relevance to metastasis would require experiments with animal
models.
In conclusion, there are many advantages to studying cancer
biology under physiological O2. In fact, compared to cell
propagation under physiological O2, ambient O2 levels are
expected to result in oxidative stress [4], mutation proneness and
persistence of transformation [63]. In this context, we have
demonstrated that growing cancer cells in vitro at low physiological
O2 (not hypoxia), compared with ambient (21%) O2 is a prudent
approach to identify and understand some of the behavioral
diversity observed in cancer.
Materials and Methods
Cell culture and Transfection
Ovarian cancer cells were grown in RPMI 1640 (A2780,
OVCAR5, OVCAR8, SKOV3) or DMEM (HeyA8 and HOC8)
Figure 7. 14-3-3 s expression and ovarian tumor metastasis. Immunohistochemical analysis of 14-3-3 s in ovarian tissues show negative
(hematoxylin stained blue nucleus) to diffuse staining pattern for 14-3-3 s (brown) in normal ovarian tissues (a–c), and a moderate increase in the
staining intensity localized to the cytoplasm is observed in the borderline ovarian tumors (d–f). In the malignant tumors without any metastatic
disease at diagnosis, 14-3-3 s expression was either absent (g), or stained at moderate to intense levels (h–i), with occasional nuclear staining (i).
Intense nuclear and cytoplasmic staining for 14-3-3 s was observed in ovarian tumors with metastatic disease, obtained from the primary site of the
disease, and a moderate to intense staining for 14-3-3 s in the cytoplasm or both nucleus and cytoplasm of the corresponding tumors obtained from
the metastatic site was observed [site of metastasis - (m) appendix, (n) lymph node and (o) omentum]. The quantitative relationship between 14-3-3
s expression and various stages of ovarian cancer progression is represented in the bar graph, and the statistical analysis for correlation of expression
with pathological grades were determined by a Fisher’s exact test.
doi:10.1371/journal.pone.0015864.g007
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(Sigma Aldrich, St.Louis, MO, Cat# F6178) and 200 units of
penicillin/streptomycin and 0.5 mg amphotericin-B. Transfection
was performed using Amaxa Nucleofector technology (Lonza) as
described previously [64]. Plasmid pcDNA 3.0 HA 14-3-3 s was
obtained from Addgene (plasmid 11946 [65]) and pcDNA 3.0 HA
empty vector was a gift from Dr. Y. Shiio, UTHSCSA. 14-3-3 s
siRNA and non-targeting dsRNA were purchased from Dharma-
con. For oxygen exposures we used Forma Series II 3110 water-
jacketed multigas incubator (Thermo Fisher scientific, Waltham,
MA) with built-in CO2 and O2 monitors and controllers. To
maintain 3% O2, the incubator received an additional supply of
nitrogen gas.
Cell proliferation
Cell proliferation was determined using Celltitre-Glo (Promega,
Madison, WI) per manufacturer instructions, as described previ-
ously [64]. Cells were seeded to a final density of 100, 200 or 400
cells per well in a 384 well plate containing 40 ml of growth medium
consisting of 2%, 6% or 10% FBS and antibiotics. Plates were then
placed in a humid chamber and returned to the incubators of
appropriate oxygen pressure. After 3 days of incubation, the
number of cells present per well was measured using Celltitre-Glo
reagent, as described previously [64]. The number of cells per well
was determined using a standard curve based on ATP concentra-
tion, as recommended by the manufacturer.
Mitotic Index
The number of mitotic cells were quantified based the method
as described [66]. Briefly, 96 well collagen coated plates were used
to seed cells at a final concentration of 1000 cells/well in their
respective media. Cells were then incubated for three days at 37uC
in 3% or 21% O2. Finally, cells were washed, resuspended in
phosphate buffered saline and stained with DAPI, as described
[66]. Images of stained cells were acquired using a Zeiss Axiovert
200M inverted fluorescent microscope using 10X magnification
and Openlab (PerkinElmer) image acquisition software. Using
Image J, a set threshold for staining intensity was used to count the
brightly stained nuclei, with obvious chromatin condensation and
the mitotic index was determined based on the ratio of number of
mitotic cells present in 1000 cells, as described [66].
Protein isolation and Western blot analysis
Protein lysates and western blot analysis were preformed as
previously described [64]. The immunoblots were probed with the
appropriate dilutions of primary antibody and visualized using
either Lumiglo (Cell signaling technology) or the ECL plus system
(GE Healthcare) with the appropriate horseradish peroxidase-
conjugated secondary antibody. The primary antibodies used were
Phospho - p53 (Ser 15), total p53, Phospho - CDC2 (Tyr 15) and
Total CDC2, Phospho - Cyclin B1 (Ser 133), total Cyclin B1,
Phospho - CDC25C (Thr 160), total CDC25C, Phsopho RB (Ser
807/811), total RB, Phospho - WEE1 (Ser 642) and total WEE1
(Cell signaling technology), p21, 14-3-3 s (Millipore) and b-actin
(Abcam). Primary antibody dilutions were used as per manufac-
turer instructions. RB and WEE1 immunoblots were performed
using 4–15% gradient gel (Criterion precast gel, Biorad).
Flow Cytometry
Cells were trypsinized and seeded to a final density of 1610
6
cells per well in a 10 cm dish containing growth medium,
antibiotics and appropriate concentrations of FBS. Dishes were
then returned to the incubators set for the different oxygen
conditions. Following three days of incubation, cells were
harvested and prepared for FACS analysis as described previously
[67]. Experiments were performed in triplicate. Stained cells were
analyzed using a FACS Canto I (BD Biosciences) flow cytometer
using an argon laser at 488 nm wavelength. Cell cycle analysis was
performed using Modfit LT (version 3.2) software (Verity Software
House).
Quantification of M phase cells
The number of cells in M phase were quantified based on
mitosis-specific histone H3 phosphorylation in the ovarian cancer
cell lines using the CellomicsH Cell Cycle Kit I (Thermo Scientific)
as per the manufacturer’s recommended protocol. Briefly, 96 well
collagen coated plates were used to seed cells at a final
concentration of 1000 cells/well in their respective media. Cells
were then incubated for three days at 37uC in 3% or 21% O2.
Control wells were treated with 1.5 mg/ml nocodazole (Sigma
Aldrich) for 16 hours, fixed with 16% formaldehyde, permeabi-
lized, blocked and stained with reagents consisting anti-phospho-
histone H3 primary antibody, as per instructions provided in the
kit. Stained cells were analyzed with a Zeiss Axiovert 200M
inverted fluorescent microscope using 10X magnification and
Openlab (PerkinElmer) image acquisition software. 100–250 cells
per replicate were counted for phospho-histone H3 positive cells.
Immunolocalization of 14-3-3 s and CDC2
A2780 cells transfected with a 14-3-3 s cDNA expression
construct or HeyA8 cells transfected with 14-3-3 s siRNA were
seeded at a final density of 10
5 cells per fibronectin (Sigma) coated
12.5 mm
2 glass coverslip mounted in each well of a 12-well plate.
Cells were maintained in complete growth medium supplemented
with 10% fetal bovine serum and allowed to grow for three days in
the presence of 21% or 3% oxygen. For the detection of 14-3-3 s
or CDC2 by immunofluorescence, cells were processed as
described previously [68]. The primary antibodies used were
mouse monoclonal 14-3-3 s at 1.0 mg/mL (Upstate) and rabbit
polyclonal total CDC2 at 1:1000 (Cell Signaling). Following a PBS
wash, the cells were incubated with secondary antibodies, goat
anti-mouse AlexaFluor 488 and goat anti-rabbit AlexaFluor 568
(Invitrogen) at 1:1000 dilution in blocking buffer for 1 hour at
room temperature. Cells were then counterstained with DAPI
(1:3000 dilution in PBS) and mounted onto microscope slides using
Fluoromount-G. Images were taken at 63X magnification using
the Zeiss Axiovert 200M inverted fluorescent microscope and
Openlab software (PerkinElmer).
Reverse Phase Protein Array
Protein lysates from 57 cancer cell lines or 205 primary ovarian
cancer tumors were spotted in RPPA slides and processed for
expression analysis, as described previously [69,70]. Data
acquisition and processing were performed as described previously
[69]. Ovarian cancer specimens were obtained from Gynecology
Tumor Tissue Bank at MD Anderson Cancer Center, following
approval from the Institutional Review Board (BT).
Normalization and Clustering
log-transformed RPPA data was first examined to remove non
ovarian cancer cell lines. We then examined all replicated
representations from the same source as annotated to reduce
down to 57 ovarian cancer cell lines or 205 patient samples (from
each source) by taking the median protein expression level of all
replicates. An additional cell-line specific normalization step was
performed in which median expression levels for each protein was
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experiments. The anchored heatmap (termed after anchored
over/under-expression orientation) was generated by requiring
RB, 14-3-3 s and CDC2 to be arranged from over-expressed to
under-expressed recursively from the given cell-line order, but
exact positions of each protein was determined by hierarchical
clustering algorithm with Euclidean distance as similarity measure
and average lineage from all cell-lines, as shown in Figure 6 A&B).
Raw data obtained from RPPA for the expression of Phospho RB,
14-3-3 s and CDC2 is provided in the supplementary tables (for
ovarian cancer cell lines, see Table S2, and for ovarian cancer
patient specimens, see Table S3)
Immunohistochemistry
Tissue arrays (OV951-1) consisting of normal and malignant
tissues from primary or metastatic sites were purchased from US
Biomax Inc. Slides were processed for immunohistochemistry and
analyzed, as described previously [71]. 14-3-3 s (Upstate) was
used at 1:50 dilution for incubation with primary antibody and
subsequent steps were performed using the Dako universal LSAB
kit with DAB as described by the manufacturer.
Statistical Analyses
To determine significant differences to proliferation under 3% or
21%O2, a Student t-test was performed, and ANOVA was performed
to compare the different cell cycle profiles with the panel of ovarian
cancer cell lines. Kaplan-Meier survival analysis with p-value
determined with log-rank test was performed using MATLAB
(Mathworks, Natick, MA) for RPPA data consisting patient
specimens. For Kaplan-Meier survival analysis the data was
censored based on patient’s vital status. Statistical analysis for the
correlation of 14-3-3 s expression with the various pathological
grades of ovarian tumors determined based on immunohistochem-
istry was analyzed by a Fisher’s exact test using R.
Supporting Information
Figure S1 Western blot analysis of phospho and total
p53, and p21, which are major upstream regulators of
G2/M cell cycle progression and the relevance to 21% or
3% O2 in ovarian cancer cells. O2 insensitive cell lines are
indicated by asterisk and italics.
(EPS)
Table S1 In vitro cell doubling time for the ovarian
cancer cell lines.
(XLS)
Table S2 Raw data from cell line RPPA for Phospho-Rb,
p53, CDC2 and 14-3-3 s expression. The table contains
following columns: 1) Unique ID, 2) Original cell-line or with
treatment, 3) Cell-line’s contributing Lab/source; 4) Cell type, 5)
Cell-line name, 6–9) log2 transformed protein expression ratios
(14-3-3 s, CDC2, p-Rb, and p53) as the raw measurement
provided by the MD Anders Cancer Center RPPA core facility.
(XLS)
Table S3 Raw data from OVSS2 RPPA for Phospho Rb,
CDC2 and 14-3-3 s expression. The table contains following
columns: 1) Unique ID, 2) Tumor ID in various databases (DBs),
3) Tumor source institution; 4) patient age at diagnosis (in months),
5) tumor stage, 6) grade (HG: high grade, LG: low grade, empty:
unknown), 7) Overall survival (in months), 8) Vital Status (0: alive,
1: dead), 9–12) log2 transformed protein expression ratios (14-3-3
s, CDC2, p53 and p-Rb) as the raw measurement provided by the
MD Anderson Cancer Center RPPA core facility.
(XLS)
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